Gregory M. Coté
Impact in
- Oncology top 2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
-
- Sarcoma Diagnosis and Treatment
Papers in
-
- Sarcoma Diagnosis and Treatment 53
- Oncology 59
- CAR-T cell therapy research 9
- HER2/EGFR in Cancer Research 8
- Lung Cancer Research Studies 8
- Vascular Tumors and Angiosarcomas 8
- Co-authors
- Edwin Choy (54 shared papers)Francis J. Hornicek (37 shared papers)Douglas B. Sawyer (9 shared papers)Nathan K. LeBrasseur (6 shared papers)Jacson Shen (16 shared papers)David C. Harmon (20 shared papers)Henry J. Mankin (16 shared papers)Thomas A. Miller (4 shared papers)
- Journals
- Journal of Clinical Oncology (42 papers)International Journal of Radiation Oncology*Biology*Physics (10 papers)Annals of Oncology (7 papers)Clinical Cancer Research (7 papers)Cancer Research (4 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Gregory M. Coté
148 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 99
- Oncology 1.1k
- Pulmonary and Respiratory Medicine 1.1k
- Rheumatology 506
- Cancer Research 406
- Pathology and Forensic Medicine 344
Countries citing papers authored by Gregory M. Coté
This map shows the geographic impact of Gregory M. Coté's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory M. Coté with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory M. Coté more than expected).
Fields of papers citing papers by Gregory M. Coté
This network shows the impact of papers produced by Gregory M. Coté. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory M. Coté. The network helps show where Gregory M. Coté may publish in the future.
Co-authors
The 25 scholars most cited alongside Gregory M. Coté, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 155 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 154 | |
| 2 | 2004 | 150 | |
| 3 | 2011 | 137 | |
| 4 | 2005 | 123 | |
| 5 | 2014 | 121 | |
| 6 | 2020 | 114 | |
| 7 | 2018 | 92 | |
| 8 | 2003 | 87 | |
| 9 | 2005 | 85 | |
| 10 | 2017 | 84 | |
| 11 | 2015 | 83 | |
| 12 | 2015 | 79 | |
| 13 | 2015 | 76 | |
| 14 | 2012 | 74 | |
| 15 | 2017 | 70 | |
| 16 | 2014 | 62 | |
| 17 | 2017 | 60 | |
| 18 | 2018 | 57 | |
| 19 | 2014 | 54 | |
| 20 | 2011 | 52 |
About Gregory M. Coté
Gregory M. Coté is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Rheumatology and Pathology and Forensic Medicine, having authored 155 papers that have together received 3.5k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (53 papers), Bone Tumor Diagnosis and Treatments (26 papers), Chromatin Remodeling and Cancer (11 papers), Cancer Mechanisms and Therapy (10 papers), CAR-T cell therapy research (9 papers), HER2/EGFR in Cancer Research (8 papers), Lung Cancer Research Studies (8 papers) and Vascular Tumors and Angiosarcomas (8 papers). The work is most often cited by research in Oncology (1.1k citations), Pulmonary and Respiratory Medicine (1.1k citations), Rheumatology (506 citations), Cancer Research (406 citations) and Pathology and Forensic Medicine (344 citations). Gregory M. Coté has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Edwin Choy, Francis J. Hornicek, Douglas B. Sawyer, Nathan K. LeBrasseur, Jacson Shen, David C. Harmon, Henry J. Mankin, Thomas A. Miller, Zhenfeng Duan and Ivan Chebib. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Annals of Oncology, Clinical Cancer Research and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.